NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: M
Post# of 174
Trxade Group NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, was showcased at several recent virtual conferences and events. In a realm not limited by location, the company’s leadership took advantage of the opportunity to boost exposure of Trxade’s innovative platform and solutions to potential investors. Among capabilities highlighted in the digital spotlight, Trxade’s business-to-consumer (“B2C”) services took center stage in relevance for today’s environment, where the most critical needs are met with a next-generation response. An article discussing this reads, “The company’s B2C operations are led via Bonum Health, which provides 24/7 access to Board-Certified Providers and Health Assessment Tools at a time when telehealth services are in high demand. Smart technology allows doctors and specialty providers to view vitals through special integrations like FitBit, iHealth, etc. Pending the outcomes of pilot programs, the company expects to make Bonum Health available nationwide.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer